Merck Gruppe

Big news! Today, we announced the opening of our newly expanded Life Science distribution center in Schnelldorf, Germany. The investment of € 180 million added 25,000 square meters to the site, almost doubling its size. It now includes a new manual down filling operation and additional space for the distribution of a wide range of products to laboratories and research facilities all around the world. Congratulations to the team! Merck Life Science

Thank you for putting a big smile on our face today! 👇 🎵

Merck has signed a definitive agreement to acquire life science company Mirus Bio for US$ 600 million (around € 550 million). Mirus Bio is a specialist in the development and commercialization of transfection reagents. These reagents play a key role in the production of viral vectors for cell and gene therapies. The acquisition will advance our integrated offering for viral vector manufacturing and complements the existing portfolio for development and production of novel modalities – a key growth area for Merck Life Science. More: https://lnkd.in/eeF5HfRf [📷 from our Carlsbad, California manufacturing facility]

In recent conversations with my family, colleagues, and industry peers in Germany but also across Europe, there has been one recurring topic – we are all witnessing an alarming rise of populism, protectionism, and a decline in solidarity. A recent Global Risk Report 2024 launched by the World Economic Forum highlighted 'societal polarization' as one of the top global risks facing our world. This underscores the urgency to unite, consider the bigger picture, work in support of international collaboration, while respecting and role-modeling our democratic principles. And these shouldn’t be negotiable. My aspiration for an inclusive world starts with upholding our commitment to core European values. Democracy, freedom, equality, and human rights are and must remain the core of our identity. These values are not only the foundation of our society but also provide the fertile ground for innovation, growth, and competitiveness. The key here is to further nurture the power of diversity to build a stronger and more united Europe. 

As 2023 draws to a close, we want to take a moment to look back at a year of transformation and progress, and the achievements that characterized 2023 and will continue to shape our work in the future. We want to say thank you to our community, our employees and all the people who share our love and passion for science and technology.   📖 Join us in revisiting the highlights of 2023 in this article!   #2023 #YearEnd #Recap

Exciting News! 🌟 We are thrilled to announce that we are ranked 68th in this year's prestigious Forbes list of the World's Best Employers! 🎉 At Merck, we prioritize creating a positive and empowering work environment, fostering growth, and embracing diversity and innovation. This accomplishment reaffirms our commitment to our employees and their well-being. Thank you to all our incredible employees who contribute to our success every day! 🙏   #ForbesWorldsBestEmployers #MakingADifference #TeamMerck https://lnkd.in/dz9QPgR9

As part of yesterdays world mental health day, we are proud to announce the launch of BeHealthy, our new global employee health program designed to support and encourage physical, mental, and social wellbeing. At Merck, we recognize that our employees are our most important strength, and investing in their health and wellbeing is crucial to our success. Our program offers a wide range of opportunities and resources to support employees in their individual health journeys such as physical activities, nutrition counseling, mental health support, and stress-management techniques. BeHealthy is not just a mere collection of initiatives; it represents a cultural shift within our organization and fuels our High-Impact Culture. We believe that investing in our employees' health and well-being not only benefits them as individuals but ultimately contributes to our collective success as a company. Join us in fostering a workplace where employees can flourish and be the best versions of themselves. Let's prioritize our health together. #BeHealthy #EmployeeWellbeing #WorldMentalHealthDay #MentalHealthAwareness Peter Guenter Merck Healthcare Patrick Metz Yvonne Romina Demir Mike Jackson Ruth Effenberger Julie Jiayu Fu Sagar Jadhav Helea Lais Soares Ferreira Aïcha Rivollet Manuela Arnold James Hipkin Dr. med. Sven Bohlmann Neil Perrett Lisa Weinacht Manel Khalfaoui Polina Novikova 刘佳洁 Rosalin K. Markus Thong

We unreservedly condemn this weekend’s brutal terrorist attack on Israel, which is bringing so much pain, violence, and suffering. We sincerely hope this conflict is resolved quickly and sustainable peace can be achieved for everyone. To our more than 400 colleagues in Israel, we are grateful you are safe. We stand resolutely with you. Your safety, and that of your families, will remain our highest priority as we continue to closely monitor the situation.  For more than 54 years, Merck has stood proudly alongside the people of Israel to build an ecosystem of tremendous innovation and resilience. To our many customers, partners, and friends, please be assured that our support and confidence in you is unwavering. On behalf of the Executive Board of Merck Group

Join us in congratulating our CEO Belén Garijo on being once again named one of Fortune's Most Powerful Women this year! This prestigious recognition honors 100 inspiring female leaders in business, cultural, political and society who are breaking barriers and paving the way for future generations. 👉https://lnkd.in/gYhtz6f8 #FortuneMPW #WomenInLeadership #LeadershipGoals

Great science receives great acknowledgement! Congratulations to Katalin Karikó and Drew Weissman for jointly winning the 2023 Nobel Prize in physiology / medicine “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against Covid-19“ Their pioneering research helped lay the essential groundwork for the rapid development of mRNA vaccines by BioNTech and others during the Covid-19 #pandemic. Their ongoing research efforts are continuing to now help the biopharma industry create an exciting new wave of mRNA medicines to treat a variety of chronic diseases.  The receipt of the Nobel Prize by Kariko and Weissmann is another great example of how science can advance human progress for all. On our end, we are proud to continue serving as an enabling provider of solutions to develop and manufacture #mRNA-based therapeutics and vaccines for many customers, including as a supplier of lipids to partners such as BioNTech SE. #innovation #science #nobelprize